Redeye comments on today’s mandatory offer from Arise’s largest shareholder, the CA Group.
Arise presented a quarter with many moving parts and one-off effects that blurred the underlying financial performance.
Redeye considers Arise’s Q1 2025 report to be a mixed bag, although largely in line with our estimates on an aggregated level.
Redeye updates its estimates ahead of Arise’s Q1 report, which is due on 29 April.
Redeye comments on Arise’s 125MW BESS divestment through its Finish subsidiary Pohjan Voima, which Arise controls to 51%.
Redeye updates its estimates and fair value range following Arise’s Q4 2024 report, which marked the end of a challenging year for the secto...
Redeye considers Arise’s Q4 2024 report to be better than expected despite facing tough comps, primarily due to unexpectedly high developmen...
Redeye updates its estimates ahead of Arise’s Q4 report, which is due on Valentine’s Day (Friday 14 February).
Redeye comments on Arise’s new SEK50m share repurchase program, refinancing its green facility of EUR52m, a new revolving green facility of ...
Redeye briefly comments on Arise’s press release from earlier this week related to the settlement agreement with a previous service supplier...
Redeye makes minor estimate changes following Arise’s Q3 report, due Thursday last week.
Redeye considers Arise’s Q3 2024 report to be in line with our estimates, adjusted for the extra revenue recognition that took place in the ...
Redeye updates its estimates ahead of Arise’s Q3 report which is due on 7 November.
Redeye comments on Arise’s divestment of a 40MW battery project for a total consideration of SEK30m + a potential earnout of SEK15m.
Redeye makes minor estimate revisions following Arise’s Q2 report, which was very much in line with Redeye’s estimates.
Redeye considers Arise’s Q2 2024 report to be solid, where the reported EBITDA was completely in line with our estimates.
Redeye updates its estimates ahead of Arise’s Q2 report, which is due on 17 July.
Redeye briefly comments on Arise's press release from last week, stating that the earn-out for project Ranasjö and Salsjöhöjden has been agr...
Redeye updates its estimates following Arise’s Q1 report yesterday, which presented a solid set of numbers that beat our estimates.
Stabilt kvartal trots avsaknad av projektförsäljningar och låga intäkter från Lebo Arise levererade ett stabilt Q1’24 trots avsaknad av proj...
Redeye considers Arise’s Q1 2024 report to be better than expected, as the production segment managed to generate a higher EBITDA than expec...
Redeye adjusts its estimates ahead of Arise’s Q1 report, which is due next week on 7 May.
Bra tillväxt och goda marginaler y/y Arise rapporterade ett starkt resultat för Q4’23 med en försäljningstillväxt på 80% och en EBIT på 65 m...
Redeye updates its estimates and fair value range following Arise’s Q4 2023 report.
Redeye thinks Arise’s Q4 2023 report came in weaker than expected.
We update our estimates ahead of Arise’s Q4 report on the back of the recently published production figure and electricity price data during...
Redeye comments on Arise’s production figure for the fourth quarter, which was released on Friday evening.
Redeye comments on Arise’s acquisition of Fenix Repower AS, a Norwegian project developer active in Ukraine and Norway, for a total consider...
Återupptagen resultatavräkning och egen produktion lyfter resultatet Arise rapporterade en solid Q3’23.
Redeye updates its fair value range following Arise’s Q3 report, which we consider very solid.
Redeye considers Arise’s Q3 report to be very solid and almost completely in line with our estimates.
Redeye is positive to see 105MW project Fasikan being divested to SCA - one of Europe’s private forest owners – with financial close today.
Redeye is pleased with Arise’s Q3 production figure of 59.
Redeye is once again positively surprised that Arise will see further revenue recognition and receive the full earn-out amount of EUR6.
Redeye updates its estimates and fair value range following Arise’s capital markets day and the new financial targets presented in conjuncti...
Redeye shares its thoughts on Arise’s new financial targets communicated on 12 September in conjunction with its capital markets day in Stoc...
Redeye is positive to Arise’s Q2 report as it beat our estimates and provided an attractive outlook for H2 2023.
Solid Q2’23 - Skaftåsen är återigen vinstavräknad Arise rapporterade en solid Q2’23.
EBITDA of SEK 69m, below ABGSCe due to project timingOwn production better, we raise '23e EBITDA by 8%The share trades at 9x P/E on 2023eQ2'...
Redeye comments on Arise’s Q2 report, which came in better than expected.
Redeye updates its estimates ahead of Arise’s Q2 report (due 18 July) following the release of Arise’s Q2 production figure, which was lower...
Redeye updates its estimates following Arise’s Q1 report.
EBITDA SEK 76m vs. ABGSCe 60m Hedges positively impacting own production The share is trading at 11x P/E on 2023e Q1 results Arise delivere...
Stark Q1’23 med stort bidrag från Production Arise rapporterade ett starkt Q1’23.
Redeye comments on Arise’s Q1 report, which came in better than expected.
Q1'23 due on Thursday, 4 May We lower '23e-'25e EBIT by 10-16% The share is trading at 14x P/E on 2023e Q1'23 expectations We expect Q1 sal...
Redeye increases its Arise estimates and fair value range following the acquisition of Pohjan Voima.
Redeye is positively surprised by Arise’s strategic partnership and acquisition of 51% of the Finnish project developer Pohjan Voima.
Q4 results Arise delivered sales of SEK 106m, which was 10% below our expectations of SEK 118m.
Redeye updates its estimates and fair value range following Arise’s Q4 report.
Stabilt kvartal utan överraskningar Arise rapporterade en försäljning på 106 mkr (79 mkr) och en justerad EBIT på 37 mkr (17 mkr) för Q4’22.
Redeye provides an initial take on Arise’s Q4 report.
EBITDA SEK 52m vs. ABGSCe SEK 66m Average realized price of SEK 850/MWh vs.
Redeye updates its estimates ahead of Arise's Q4 report, which is due on February 16.
Q4 report on Thursday, 16 February Stronger winds, but again below budget EBIT of SEK 51m, with a margin of 43.
Redeye updates its estimates and fair value range following Arise’s Q3 report, where reported EBITDA was at an all-time high, driven by the ...
Development starkt i Q3 medan Production var svagt Arise rapporterade ett starkt Q3'22 med EBIT om 697 mkr (61), främst drivet av försäljnin...
We lower ’23e EBIT by 4% Negatively affected by hedge prices The share is trading at ~6x P/E on 2023e Q3’22 results Arise delivered strong ...
EBITDA SEK 713m vs. ABGSCe SEK 718m Renewable energy project portfolio of 2,600 MW Conference call at 11.
Redeye comments on Arise’s Q3 report, which was the strongest quarter in the company’s history.
Q3 due on Wednesday, 9 November Sale of Kölvallen the key EBIT driver Share trading at ~3x adj.
Following the Kölvallen deal with great results, we increase our estimates as well as base case valuation, driven by higher near-term earnin...
Stark Q2 och försäljning av Kölvallen lyser Arises nettoomsättning uppgick till 53 (36) mkr och EBIT till 10 (-6) mkr; en tydlig förbättring...
Q2 report overshadowed by Kölvallen divestment Kölvallen to add SEK 690m to Q3 Value range at SEK 80-130 Q2 below expectations due to timing...
Redeye considers Arise Q2 figures to be somewhat on the weak side, mainly due to weaker winds in the production segment, as well as negative...
Redeye is impressed with Arise’s sale of Kölvallen, with an expected EBITDA contribution of about EUR65m-EUR90m until 2025 vs.
Egen produktion fortsätter att glänsa Arise nettoomsättning uppgick till 88 (47) mkr och EBIT till 46 (7) mkr; en tydlig förbättring jämfört...
Q1’22 EBITDA in line with our expectation We leave ’22e-’23e EBITDA roughly unchanged Maintain SEK 60-120 fair value range Strong electrici...
Redeye considers Arise Q1-figures solid with strong operational cash flow, driven mainly by higher electricity prices but also stronger wind...
Q1’22 EBITDA of SEK 61m, in line with ABGSCe Production EBITDA SEK 65m above ABGSCe SEK 59m Limited earnings revisions expected Q1’22 overv...
